Abstract:Recognition of hepatitis C virus (HCV)-infected hepatocyes and interferon (IFN) induction are critical in antiviral immune response. We hypothesized that cell-cell contact between plasmacytoid dendritic cells (pDCs) and HCV-infected cells was required for IFN- induction through the involvement of cell-surface molecules. Coculture of human peripheral blood mononuclear cells (PBMCs) with genotype 1a full-length (FL) HCV genomic replicon cells or genotype 2a Japanese fulminant hepatitis type 1 (JFH-1) virus-infected hepatoma cells (JFH-1), and not with uninfected hepatoma cells (Huh7.5), induced IFN- production. Depletion of pDCs from PBMCs attenuated IFN- release, and purified pDCs produced high levels of IFN- after coculture with FL replicons or JFH-1-infected cells. IFN- induction by HCV-containing hepatoma cells required viral replication, direct cell-cell contact with pDCs, and receptor-mediated endocytosis. We determined that the tetraspanin proteins, CD81 and CD9, and not other HCV entry receptors, were required for IFN- induction in pDCs by HCV-infected hepatoma cells. Disruption of cholesterol-rich membrane microdomains, the localization site of CD81, or inhibition of the CD81 downstream molecule, Rac GTPase, inhibited IFN- production. IFN- induction involved HCV RNA and Toll-like receptor (TLR) 7. IFN- production by HCV-infected hepatoma cells was decreased in pDCs from HCV-infected patients, compared to healthy controls. We found that preexposure of healthy PBMCs to HCV viral particles attenuated IFN- induction by HCV-infected hepatoma cells or TLR ligands, and this inhibitory effect could be prevented by an anti-HCV envelope glycoprotein 2-blocking antibody. Conclusion: Our novel data show that recognition of HCV-infected hepatoma cells by pDCs involves CD81- and CD9-associated membrane microdomains and induces potent IFN- production. (HEPATOLOGY 2013;58:940-949)

Identification and Expression of Human CD81 Gene on Murine NIH/3T3 Cell Membrane.

Stably Silencing Of Cd81 Expression By Small Interfering Rnas Targeting 3 '-Ntr Inhibits Hcv Infection

Phage Display Selection on Whole Cells Yields a Small Peptide Specific for HCV Receptor Human CD81

Selection Of Aphage-Displayed Peptide Recognized By Monoclonal Antibody Directed Blocking The Site Of Hepatitis C Virus E2 For Human Cd81

Over-expressing Human CD81 in Huh7 Cells Enhance Hepatitis C Virus Infection

Cd81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

Biopanning and Identification of Peptides Capable to Inhibit the Interaction Between Hcd81 and HCV E2 Protein

Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells

Novel function of CD81 in controlling hepatitis C virus replication

Cloning and Expression of the Human CD81-LEL Gene in E. Coli

Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner

Hepatitis C Virus Protects Human B Lymphocytes from Fas-Mediated Apoptosis Via E2-CD81 Engagement

Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors

Activation of Intracellular MAPK/ERK Initiated by Hepatitis C Virus Envelope Protein E2 in HepG2 Cells.

CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.

Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry

A Conserved Domain of HCV E2 Glycoprotein Interacts with Human CD81 and Induces Interferon-Gamma Secretion from Peripheral Blood Mononuclear Cells

Identification of a Murine CD4+ T-lymphocyte Response Site in Hepatitis C Virus Core Protein.

Characterization of Monoclonal Antibodies Against Hepatitis C Virus Nonstructural Protein 3: Different Antigenic Determinants from Human B Cells

CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection

Cross-linking of CD81 by HCV-E2 Protein Inhibits Human Intrahepatic Plasmacytoid Dendritic Cells Response to CpG-ODN